RAF1 scaffold integrity shapes chemogenetic degradation outcomes in KRAS-driven lung cancer
Laura de la Puente Ovejero, Ana Domostegui, Inés María García-Pérez, Gonzalo Aizpurua, Lucia Lomba-Riego, Pilar Ximénez‐Embún, Cristina Mayor‐Ruiz, Mariano Barbacid, Sara García‐Alonso
This study shows that chemogenetic degradation of RAF1 in KRAS-driven lung cancer does not replicate genetic ablation outcomes due to scaffold disruption.
bioRxiv · Jul 6, 2026 · PreprintCancer Biology